NSE · GKB
GKB Ophthalmics Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹6 Cr with net profit ₹-0 Cr — a -7.81% net margin, versus 0.74% the period before.
Shareholding
As of 2026-06-30
- Promoter51.15%
- Public47.07%
- FII1.79%
2,557 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.23× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Personal Care - Indian · ranked #11 of 14 by market cap · medians across 12 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Lenskart Solutions Ltd. | ₹1,20,630 Cr | 182.99 | 13.8 | 5.65% | 6.8% |
| Godrej Consumer Products Ltd. | ₹88,946 Cr | 42.84 | 7.03 | 14.71% | 12.05% |
| Dabur India Ltd. | ₹66,781 Cr | 33.67 | 5.85 | 16.59% | 14.55% |
| Cupid Limited | ₹37,261 Cr | 271.67 | 82.65 | 24.01% | 30.35% |
| Emami Limited | ₹16,179 Cr | 21.36 | 5.53 | 26.51% | 19.12% |
| Jyothy Labs Limited | ₹7,174 Cr | 19.59 | 3.5 | 18.07% | 13.01% |
| Bajaj Consumer Care Ltd. | ₹6,833 Cr | 30.65 | 9.05 | 25.24% | 18.05% |
| Radix Industries (India) Ltd. | ₹201 Cr | 68.56 | 8.61 | 13.72% | 6.41% |
| Thrive Future Habitats Limited | ₹97 Cr | — | 2.13 | -1.94% | -132.28% |
| JHS Svendgaard Laboratories Ltd. | ₹71 Cr | — | 0.41 | -1.1% | -1.74% |
| GKB Ophthalmics Ltd.(this company) | ₹33 Cr | 6.53 | 0.62 | 5.53% | 2.16% |
AI analysis
AI-generated · google/gemini-2.5-flashGKB Ophthalmics Ltd. (533212), operating in the FMCG sector, has a market capitalization of Rs 29 Cr. The company reported an EPS of 5.79 and a Book Value of 104.81. The Return on Equity (ROE) is 5.53% and Return on Capital Employed (ROCE) is 11.7356%.
Positives
- +The company's profit margin is high at 81.18%.
- +Debt-to-equity ratio is low at 0.23.
- +Promoter holding is above 50% at 51.1483%.
Negatives
- −The company's annual net profit was negative, at -2.48 Cr in Mar 2025 and -1.88 Cr in Mar 2026.
- −Quarterly net profit was negative for several periods, including -2.03 Cr in Dec 2024 and -3.55 Cr in Mar 2025.
- −The company reported a dividend yield of 0%.
Financial Performance
The company's quarterly revenue reached Rs 56.79 Cr in Dec 2025, and Rs 29.79 Cr in Mar 2026. Net profit was Rs 0.44 Cr in Dec 2025 and Rs 0.19 Cr in Mar 2026. The EBITDA for the quarter ending Dec 2025 was Rs 1.7 Cr, increasing to Rs 3.12 Cr in Mar 2026. Annual revenue for Mar 2026 was reported as Rs 6.4 Cr, with a net loss of Rs 1.88 Cr.
Profitability & Returns
GKB Ophthalmics Ltd. recorded a profit margin of 81.18%. The Return on Equity (ROE) stands at 5.53% and Return on Capital Employed (ROCE) is 11.7356% based on available data. The PE ratio is 9.93.
Balance Sheet
The company maintains a debt-to-equity ratio of 0.23, indicating a low level of leverage. The book value per share is Rs 104.81. The company has a dividend yield of 0%.
Ownership & Pledges
There are no shares pledged by the promoters. The number of shareholders as of June 30, 2026, is 2557.
Data as of — price: 2026-09-10 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.